Preview

Rational Pharmacotherapy in Cardiology

Advanced search

Search


Order results by:     
 
Issue Title
 
Vol 9, No 3 (2013) ECONOMIC EVALUATION OF COMBINED THERAPY OF ARTERIAL HYPERTENSION BY MARKOV’S MODELING Abstract  similar documents
N. S. Maksimchuk-Kolobova, E. I. Tarlovskaya, S. V. Malchikova
"... maximal number of quality adjusted life years (QALY) due to LVM regression (5.016 years). L/A combination ..."
 
Vol 11, No 5 (2015) Cost-effectiveness of new oral anticoagulants in the treatment and secondary prevention of venous thromboembolism Abstract  similar documents
A. V. Rudakova
"... Aim. To assess the cost-effectiveness of apixaban in the treatment and secondary prevention ..."
 
Vol 10, No 2 (2014) PRIMARY PREVENTION OF MYOCARDIAL INFARCTION IN MIDDLE-AGED MALES (15-YEAR FOLLOW-UP): CLINICAL AND ECONOMIC ASPECTS OF THE PROBLEM Abstract  PDF (Eng)  similar documents
A. M. Kalinina, A. V. Kontsevaya
"... ” (QALYS) for 1000 persons in the active prevention group were 53 and 51 years, respectively during the 5 ..."
 
Vol 10, No 3 (2014) COST-EFFECTIVENESS OF APIXABAN AS COMPARED WITH WARFARIN AND ACETYLSALICYLIC ACID IN PATIENTS WITH NON-VALVULAR ATRIAL FIBRILLATION IN THE RUSSIAN FEDERATION Abstract  similar documents
A. V. Rudakova, V. A. Parfenov
"... in patients with NVAF in the Russian Federation. Aim. To evaluate the cost-effectiveness ratio of apixaban ..."
 
Vol 9, No 1 (2013) CHARACTERISTICS OF THE TYPES OF LEFT VENTRICULAR REMODELING AMONG WORKING AGE MEN WITH ISCHEMIC HEART DISEASE, LIVING IN ONE OF THE MOUNTAIN REGIONS OF AZERBAIJAN Abstract  similar documents
N. R. Ismaylova, F. A. Kuliev, A. F. Zeynalov
"... on the calculation ofLV mass (LVM) and the LVM index (LVMI)]. The most reliable LVH detection was observed ..."
 
Vol 14, No 2 (2018) PHARMACOECONOMIC ANALYSIS OF CHRONIC HEART FAILURE DRUG THERAPY IN PATIENTS WITH COMORBID CONDITIONS Abstract  similar documents
S. K. Zyryanov, A. E. Cheberda, D. Yu. Belousov
"... in market situation. Results. Cost-effectiveness ratio for sacubitril/valsartan is 301,145.7 rub. per QALY ..."
 
Vol 11, No 4 (2015) EVALUATION OF COST-EFFECTIVENESS OF PLATELET REACTIVITY ANALYSIS USING THE VERIFYNOW P2Y12 ASSAY IN PATIENTS AFTER ACUTE CORONARY SYNDROME Abstract  similar documents
A. V. Rudakova, N. V. Lomakin
"... . To assess the cost-effectiveness of VerifyNow P2Y12 platelet reactivity testing in patients after ACS ..."
 
Vol 11, No 1 (2015) PHARMACOECONOMIC ASPECTS OF APIXABAN FOR PREVENTION OF THROMBOEMBOLIC EVENTS IN PATIENTS WITH ATRIAL FIBRILLATION Abstract  similar documents
A. V. Rudakova
"... of any medical technology is economic value and cost-effectiveness. The objective of this review ..."
 
Vol 11, No 3 (2015) PHARMACOECONOMIC ASPECTS OF THE PREVENTION OF VENOUS THROMBOEMBOLIC EVENTS AFTER LARGE JOINTS REPLACEMENT Abstract  similar documents
A. V. Rudakova
"... or oral anticoagulants that differ significantly in their efficacy, safety and cost of the therapy. Aim ..."
 
Vol 7, No 2 (2011) COST-EFFECTIVENESS EVALUATION OF PREHOSPITAL THROMBOLYSIS WITH TENECTEPLASE Abstract  similar documents
V. V. Omel'yanovskiy, E. V. Derkach, P. M. Khaylov, S. N. Tereshchenko
"... Aim. To evaluate clinical and cost effectiveness of different reperfusion strategies in myocardial ..."
 
Vol 5, No 5 (2009) THE COMPARATIVE COST-EFFICACY ANALYSIS OF VARIOUS ANTIHYPERTENSIVE THERAPIES Abstract  similar documents
S. V. Malchikova, E. I. Tarlovskaya
"... Aim. To perform the comparative cost-efficacy analysis of various antihypertensive therapies ..."
 
Vol 7, No 2 (2011) SOCIO-ECONOMIC DAMAGE BY ACUTE CORONARY SYNDROME IN RUSSIAN FEDERATION Abstract  similar documents
A. V. Kontsevaya, A. M. Kalinina, I. E. Koltunov, R. G. Oganov
"... . Material and Methods. Direct costs and economic losses associated with ACS were estimated. The structure ..."
 
Vol 7, No 5 (2011) ANALYSIS OF DIRECT COSTS ASSOCIATED WITH THE USE OF WARFARIN IN PATIENTS WITH ATRIAL FIBRILLATION Abstract  similar documents
Yu. B. Belousov, I. S. Yavelov, D. Yu. Belousov, E. V. Afanasieva
"... . The study was performed based on methodology for Cost of Illness evaluation. Expenses associated with INR ..."
 
Vol 8, No 1 (2012) ANALYSIS OF COST STRUCTURE FOR PHARMACOTHERAPY OF PATIENTS WITH STABLE ANGINA (THE CASE OF CARDIOLOGY DEPARTMENT OF TVER REGIONAL CLINICAL HOSPITAL) Abstract  similar documents
M. A. Demidova, N. N. Kirilenko
"... Aim. To analyze the cost structure for pharmacotherapy of patients with stable angina (SA ..."
 
Vol 8, No 3 (2012) PHARMACOECONOMIC ASPECTS OF NICOTINE ADDICTION TREATMENT IN PATIENTS WITH ANGINA REQUIRING CARDIAC SURGERY Abstract  similar documents
A. V. Rudakova, M. S. Berezhnova
"... the rejection of it are an important part of the treatment. Aim. To analyze the cost effectiveness ..."
 
Vol 7, No 5 (2011) PSYCHOMETRIC VISUAL ANALOGUE SCALE IN ASSESSMENT OF THE STABLE ANGINA SEVERITY AND EFFICACY OF ANTIANGINAL THERAPY Abstract  similar documents
E. V. Solyanik
"... «Шкалы состояния пациента» и Сиэттлского опросника качества жизни (КЖ) больных стенокардией (Seattle ..."
 
Vol 9, No 4 (2013) COMPARISON OF DIRECT COSTS OF DABIGATRAN AND WARFARIN THERAPY IN PATIENTS WITH NON-VALVULAR ATRIAL FIBRILLATION DURING PREPARATION FOR ELECTIVE CARDIOVERSION IN THE REAL CLINICAL PRACTICE Abstract  similar documents
L. E. Kuvshinova, N. V. Furman, P. V. Dolotovskaya, Ya. P. Dovgalevsky
"... Aim. To compare direct medical costs of dabigatran and warfarin therapy in patients with non ..."
 
Vol 4, No 3 (2008) INFLUENCE OF HEALTH SCHOOL TRAINING OF PATIENTS WITH ISCHEMIC HEART DISEASE ON PHARMACOTHERAPY PROFILE AND COST (АВС/VEN ANALYSIS) Abstract  similar documents
A. V. Kontsevaja, А. М. Kalinina, E. J. Spivak
"... Aim. To study influence of patient training in Health School on pharmacotherapy profile and cost ..."
 
Vol 7, No 5 (2011) ECONOMIC BENEFITS OF LEFT VENTRICULAR HYPERTROPHY REGRESSION IN PATIENTS WITH ARTERIAL HYPERTENSION Abstract  similar documents
E. I. Tarlovskaya, N. S. Maksimchuk, S. V. Malchicova, M. V. Avksentieva, I. E. Sapozhnikova, Y. A. Balandina
"... 516 772.42 RUR for every 1 000 patients. It would reduce the total costs per patient during 10 years ..."
 
Vol 8, No 1 (2012) PHARMACOECONOMIC EVALUATION OF DABIGATRAN VS WARFARIN IN CARDIOVASCULAR EVENTS PREVENTION IN PATIENTS WITH NON-VALVULAR ATRIAL FIBRILLATION Abstract  similar documents
Yu. B. Belousov, V. Yu. Mareev, I. S. Yavelov, D. Yu. Belousov
"... the cost-effectiveness of dabigatran etexilate versus warfarin prescribed in “real-world” settings from ..."
 
Vol 9, No 1 (2013) CLINICAL AND COST EFFECTIVENESS OF PREVENTIVE COUNSELING OF YOUNG PATIENTS WITH ARTERIAL HYPERTENSION IN PRIMARY HEALTH CARE Abstract  similar documents
M. I. Shupina, O. Ju. Korennova, E. N. Loginova
"... Aim. To study clinical and cost effectiveness of training of young patients with arterial ..."
 
Vol 8, No 1 (2012) CHANGES IN THE COSTS OF HYPERTENSIVE CRISIS THERAPY DUE TO OPTIMIZATION OF DRUG SUPPLY IN THE PRE-ADMISSION CARE Abstract  similar documents
N. I. Gaponova, N. F. Plavunov, V. L. Baratashvili
"... Aim. To assess the changes in the costs of treatment of patients with hypertensive crisis (HC ..."
 
Vol 2, No 1 (2006) ANTIHYPERTENSIVE TREATMENT WITH COMBINED DRUG OF LOSARTAN AND HYDROCHLOROTHIAZIDE Abstract  similar documents
R. M. Linchak, K. M. Shumilova, A. D. Martinyuk, T. A. Gusaim, E. V. Semyonova, L. G. Zhirova, S. A. Boitsov
"... качество жизни. Результаты.  Через 2 нед терапии отмечено снижение офисного систолического артериального ..."
 
Vol 4, No 1 (2008) COMPARATIVE EFFICACY OF LONG-TERM ANTIHYPERTENSIVE MONOTHERAPY IN PATIENTS WITH ARTERIAL HYPERTENSION AT THE WORK PLACE Abstract  similar documents
О. N. Antropova, I. V. Osipova, E. I. Kuznetzova, N. V. Piricova, I. I. Curbatova
"... желудочка (ГЛЖ), качество жизни машинистов и помощников машинистов с артериальной гипертонией на рабочем ..."
 
Vol 10, No 6 (2014) VALIDATION OF THE MACNEW QUESTIONNAIRE FOR THE ASSESSMENT OF HEALTH-RELATED QUALITY OF LIFE IN PATIENTS WITH ISHEMIC HEART DISEASE Abstract  PDF (Eng)  similar documents
N. V. Pogosova, A. A. Kursakov, I. H. Boycharov, S. Höfer, N. Oldridge
"... качеству жизни, связанному со здоровьем (КЖСЗ). Во многих странах для оценки КЖСЗ у больных ишемической ..."
 
Vol 7, No 6 (2011) MY LIFE - CARDIOLOGY  similar documents
N. V. Dolgushina
"... 776 Рациональная Фармакотерапия в Кардиологии 2011;7(6) МОЯ ЖИЗНЬ — КАРДИОЛОГИЯ — Наталья ..."
 
Vol 7, No 4 (2011) VALUE OF THERAPEUTIC EQUIVALENCE IN SUBSTITUTION OF ORIGINAL DRUG WITH GENERIC BY EXAMPLE OF FOSINIPRIL Abstract  similar documents
N. P. Kutishenko, S. Yu. Martsevich, Zh. D. Kobalava, E. K. Shavarova
"... with arterial hypertension (HT) of 1-2 degrees, and to evaluate the cost effectiveness of original drug ..."
 
Vol 7, No 3 (2011) COSTS OF THE HEALTH CARE IN RUSSIA ASSOCIATED WITH SMOKING Abstract  similar documents
A. V. Kontsevaya, A. M. Kalinina
"... Aim. To analyze costs of health care in Russia associated with smoking in 2009. Material ..."
 
Vol 5, No 2 (2009) CORRECTION OF PSYCHO-AUTONOMIC DISORDERS IN WOMEN WITH ARTERIAL HYPERTENSION DURING POSTMENOPAUSAL PERIOD Abstract  similar documents
G. G. Semenkova, E. E. Matvienko
"... состояние, самочувствие, уровень тревоги, вегетативные расстройства, качество жизни (КЖ). Результаты ..."
 
Vol 4, No 5 (2008) CLINICAL AND ECONOMICAL ASSESSMENTS OF METOPROLOL TARTRATE/SUCCINATE USAGE IN PATIENTS WITH ISCHEMIC HEART DISEASE Abstract  similar documents
M. V. Soura
"... ’s comparative cost analysis on metoprolol tartrate (Betaloc) and metoprolol succinate (Betaloc ZOK) usage ..."
 
Vol 8, No 2 (2012) QUALITY OF LIFE AND ITS DYNAMICS IN PATIENTS WITH ATRIAL FIBRILLATION AFTER LEAVING THE INTERNATIONAL CLINICAL TRIAL Abstract  similar documents
E. L. Artanova, L. E. Kon'shina, I. M. Sokolov, Y. G. Shvarts
"... Цель. Изучить изменения качества жизни у пациентов с фибрилляцией предсердий (ФП), получавших ..."
 
Vol 5, No 2 (2009) EFFECT OF ANTIHYPERTENSIVE DRUGS ON QUALITY OF LIFE IN PATIENTS WITH ARTERIAL HYPERTENSION Abstract  similar documents
G. F. Andreeva, A. D. Deev, V. M. Gorbunov
"... качество жизни (КЖ) пациентов со стабильным течением артериальной гипертонии (АГ). Материал и методы ..."
 
Vol 4, No 4 (2008) EFFICACY OF CHRONIC HEART FAILURE COMBINED THERAPY DURING PERLINDOL USAGE IN ELDERLY POST INFARCTION PATIENTS WITH PSYCHOSOMATIC DISORDERS Abstract  similar documents
M. E. Statsenko, I. A. Tyschenko
"... помощи опросника Бэка и шкалы HADS, качество жизни по данным Сиэтлского, Миннесотского опросников и MOS ..."
 
Vol 6, No 4 (2010) ECONOMIC EFFICIENCY OF THE IMPLEMENTATION OF THE PROGRAM OF CARDIOVASCULAR DISEASES MULTIFACTORIAL PREVENTION IN THE ORGANIZED COLLECTIVE OF TECHNICAL RESEARCH INSTITUTE Abstract  similar documents
A. V. Kontsevaya, A. M. Kalinina, S. V. Belonosova, J. M. Pozdnjakov, M. B. Khudyakov
"... consultation. Costs associated with cardiovascular diseases and risk factors (medical care consumption ..."
 
Vol 14, No 6 (2018) Specific Antidotes for Direct Oral Anticoagulants in Life-Threatening Bleeding Abstract  PDF (Eng)  similar documents
A. B. Sumarokov, L. I. Buryachkovskaya, N. V. Lomakin
"... антидота при остановке угрожающих жизни кровотечений у больных, получавших ПОАК. Прием ПОАК сопровождается ..."
 
Vol 9, No 1 (2013) PHARMACOEPIDEMIOLOGICAL AND PHARMACOECONOMIC STUDIES OF ANTIHYPERTENSIVE TREATMENT IN RUSSIA. Analytical Review Abstract  similar documents
T. S. Romanenko, A. V. Kontsevaya, S. V. Fitilev
"... therapy, conducted during the last decades inRussia. Despite the increased interest to the issue of cost ..."
 
Vol 10, No 5 (2014) CLINICAL EFFICACY OF LOOP DIURETIC TORASEMIDE IN TREATMENT OF PATIENTS WITH CHRONIC HEART FAILURE. RESULTS OF KAZAKHSTAN MULTICENTER STUDY "POET" Abstract  similar documents
S. F. Berkinbaev, G. A. Dzhunusbekova, A. K. Isabekova
"... миокарда, в том числе повышение его систолической функции на 8,2%, улучшение качества жизни на 30,1% по ..."
 
Vol 10, No 3 (2014) THE CAPABILITIES OF A REGISTER AS A QUALITY CONTROL OF THE PHARMACOTHERAPY IN OUTPATIENTS AT HIGH RISK OF CARDIOVASCULAR COMPLICATIONS (THE "LIS-1" REGISTER) Abstract  similar documents
M. L. Ginzburg, S. Y. Martsevich, N. P. Kutishenko, Y. V. Lukina, A. D. Deev
"... осложнений. Ключевые слова: острый инфаркт миокарда, регистр, прогноз жизни, оценка лекарственной терапии ..."
 
Vol 1, No 1 (2005) MENOPAUSE AND CARDIOVASCULAR RISK Abstract  similar documents
D. A. Anichkov, N. A. Shostak, A. D. Zhuravleva
"... проводиться с помощью изменения образа жизни, липидснижающей и антигипертензивной терапии. ..."
 
Vol 6, No 4 (2010) QUALITY OF LIFE AND COMPLIANCE TO THERAPY IN PATIENTS FOLLOWING SUCCESSFUL TRANSLUMINAL CORONARY ANGIOPLASTY, WHO WERE PRESCRIBED LESCOL XL (FLUVASTATIN) ADDED TO STANDARD THERAPY. RESULTS OF THE LESQOL OPEN-LABEL OBSERVATIONAL STUDY Abstract  similar documents
A. V. Susekov, V. A. Bulatov, A. V. Vigdorchik
"... Цель. Основной целью исследования LESQOL было изучение качества жизни и приверженности проводимой ..."
 
Vol 5, No 4 (2009) CHANGE OF CARDIOVASCULAR RISK FACTORS AND QUALITY OF LIFE IN YOUNG HYPERTENSIVE PATIENTS AS A RESULT OF PREVENTIVE CONSULTATION IN PRIMARY HEALTH CARE Abstract  similar documents
M. I. Shupina
"... Цель. Оценить динамику показателей качества жизни (КЖ) у пациентов молодого возраста с ..."
 
Vol 5, No 5 (2009) LONG-TERM THERAPY WITH INDAPAMIDE IN ELDERLY AND SENILE PATIENTS WITH HYPERTENSION: CARDIORENOPROTECTIVE EFFECTS AND INFLUENCE ON QUALITY OF LIFE Abstract  similar documents
M. E. Statsenko, T. G. Sherbakova, S. V. Belenkova, O. E. Sporova
"... гипертонией (АГ) пожилого и старческого возраста и ее влияние на качество жизни. Материал и методы ..."
 
Vol 7, No 6 (2011) EFFICACY OF CORONARY STENTING AND BASIC PHARMACOTHERAPY IN ELDERLY AND SENILE PATIENTS: THE RESULTS OF LONG-TERM PROSPECTIVE FOLLOW-UP Abstract  similar documents
L. R. Mirzakhanova
"... Цель. Провести сравнительную оценку выживаемости и качества жизни у больных гериатрического ..."
 
Vol 8, No 6 (2012) THE LIS STUDY (LYUBERTSY STUDY ON MORTALITY RATE IN PATIENTS AFTER ACUTE MYOCARDIAL INFARCTION). EVALUATION OF DRUG THERAPY. PART 2. INFLUENCE OF PREVIOUS DRUG TREATMENT ON LONG-TERM LIFE PROGNOSIS Abstract  similar documents
S. Yu. Martsevich, M. L. Gynzburg, N. P. Kutishenko, A. D. Deev, V. P. Smirnov, L. U. Drozdova, E. V. Daniels, A. V. Fokina
"... ОИМ значимо улучшал отдаленный прогноз жизни [относительный риск (ОР) 0,70 и 0,66, соответственно]. В ..."
 
Vol 6, No 3 (2010) QUALITY OF LIFE AND COMPLIANCE TO THERAPY IN PATIENTS FOLLOWING SUCCESSFULTRANSLUMINAL CORONARY ANGIOPLASTY, WHO WERE PRESCRIBED FLUVASTATIN EXTENDED RELEASE ADDED TO STANDARD THERAPY. PROTOCOL OF THE OPEN-LABEL OBSERVATIONAL STUDY Abstract  similar documents
A. V. Susekov, V. A. Bulatov, A. V. Vigdorchik
"... Цель. Изучить качество жизни и приверженность терапии у пациентов, перенесших успешную ..."
 
Vol 2, No 4 (2006) REPORT ON OPEN MULTICENTRAL RESEARCH PROGRAM “PRIORITY” IN CLINICAL PRACTICE. (PEKTROL – QUALITY OF LIFE IN PATIENTS WITH STABLE ANGINA PECTORIS TREATED WITH ISOSORBIDE-5-MONONITRATE IN LONG-ACTING PRESENTATION) Abstract  similar documents
Yu. A. Karpov
"... терапию нитратами и сопутствующую терапию. Оценивали качество жизни больных посредством анкетирования ..."
 
Vol 12, No 1 (2016) The main factors affecting the long-term outcomes in patients after acute cerebrovascular disorder: results of the LIS-2 study Abstract  similar documents
S. Yu. Martsevich, N. P. Kutishenko, A. V. Suvorov, A. V. Zagrebelnyy, M. L. Ginzburg, A. D. Deev
"... Цель. Оценить отдаленный прогноз жизни больных, перенесших мозговой инсульт (МИ), и определить ..."
 
Vol 12, No 6 (2016) THE ASSESSMENT OF NICORANDIL EFFECT ON THE QUALITY OF LIFE IN PATIENTS WITH STABLE ANGINA IN THE "KVAZAR" STUDY Abstract  similar documents
S. Yu. Martsevich, N. P. Kutishenko, A. D. Deev
"... протекающей ишемической болезнью сердца (ИБС) на показатели качества жизни (КЖ). Материал и методы. В двойное ..."
 
Vol 13, No 1 (2017) QUALITY OF LIFE, CLINICAL AND BIOCHEMICAL PARAMETERS IN HYPERTENSIVE PATIENTS WITH COMORBID CONDITIONS Abstract  similar documents
E. B. Akhmedova, B. U. Mardanov, K. K. Badeynikova, M. N. Mamedov
"... жизни больных артериальной гипертонией (АГ) и коморбидными состояниями. Материал и методы. В ..."
 
Vol 13, No 1 (2017) CLINICAL AND ECONOMICAL COMPARISON OF RIVAROXABAN AND APIXABAN USE IN PATIENTS WITH NON-VALVULAR ATRIAL FIBRILLATION Abstract  similar documents
S. V. Nedogoda, I. N. Barykina, A. S. Salasiuk, V. O. Smirnova
"... Aim. To compare cost-effectiveness of the use of direct factor Xa inhibitors rivaroxaban ..."
 
Vol 5, No 4 (2009) TO THE 110-TH ANNIVERSARY OF RENIN FINDING. FIGHT OF TITANS: ANGIOTENSIN CONVERTING ENZYME INHIBITORS AND SARTANS Abstract  similar documents
L. N. Malay, A. N. Miroshnichenko, B. V. Sharykin, V. V. Konurovsky
"... , treatment costs and safety). The place of ACE inhibitors and ARB in modern therapy of cardiovascular ..."
 
Vol 5, No 3 (2009) CLINICAL AND ECONOMICAL RATIONALES OF CARDIOVASCULAR RISK EVALUATION AT WORKPLACE Abstract  similar documents
A. V. Kontsevaya, A. M. Kalinina, Yu. M. Pozdnyakov, S. V. Belonosova, M. B. Khudyakov
"... (with estimation of the total costs, costs for one studied person and costs for revealing of one person needed ..."
 
Vol 14, No 2 (2018) ECONOMIC BURDEN OF CARDIOVASCULAR DISEASES IN THE RUSSIAN FEDERATION IN 2016 Abstract  PDF (Eng)  similar documents
A. N. Kontsevaya, O. M. Drapkina, Yu. A. Balanova, A. E. Imaeva, E. I. Suvorova, M. B. Khudyakov
"... (RF) in 2016, including the direct costs and the economic losses caused by reduced productivity ..."
 
Vol 3, No 5 (2007) EFFECTS OF BETA-BLOCKER METOPROLOL ON QUALITY OF LIFE IN ELDERLY PATIENTS WITH CHRONIC HEART FAILURE Abstract  similar documents
I. V. Vologdina
"... тартрата на качество жизни пациентов старческого возраста с хронической сердечной недостаточностью (ХСН ..."
 
Vol 2, No 2 (2006) EFFECT OF LISINOPRIL AND ENALAPRIL ON QUALITY OF LIFE AND BLOOD PRESSURE DAILY PROFILE IN PATIENTS WITH STABLE ARTERIAL HYPERTENSION. Abstract  similar documents
G. F. Andreeva, A. D. Deev, V. M. Gorbunov
"... Цель. Сопоставить влияние на качество жизни (КЖ) и суточный профиль АД длительного приема ..."
 
Vol 14, No 5 (2018) Economic losses due to low coverage of lipid-lowering therapy in patients with cardiovascular diseases in the Russian Federation Abstract  similar documents
Yu. A. Balanova, A. V. Kontsevaya, A. E. Imaeva, O. I. Karpov, M. B. Khudyakov
"... in 2016, including direct costs of the health care system  and indirect economic losses due to premature ..."
 
Vol 13, No 2 (2017) THESES OF PSYCHOSOMATIC MEDICINE Abstract  similar documents
F. I. Belyalov
"... , increase healthcare costs. Antidepressants decrease severity of anxiety and depression, as well as diminish ..."
 
Vol 10, No 4 (2014) RATIONAL PHARMACOTHERAPY BASED ON PHARMACOECONOMIC DATA AUDIT: PRINCIPLES AND APPLICATION IN BULGARIA Abstract  similar documents
T. Vekov
"... (Cost-effectiveness analysis – СЕА), экономическую оценку добавочной стоимости для пациента, сравнение ..."
 
Vol 8, No 2 (2012) PRELIMINARY RESULTS OF COMPARATIVE PHARMACOECONOMIC PROSPECTIVE STUDY OF DIFFERENT THERAPIES OF ARTERIAL HYPERTENSION Abstract  similar documents
E. I. Tarlovskaya, N. S. Maksimchuk, S. V. Malchikova, M. V. Avksentieva
"... (LVMI) were considered. Cost-effectiveness method of analysis was used. Results. In V/A group 75 ..."
 
Vol 1, No 3 (2005) CARDIORENAL RELATIONS AND QUALITY OF LIFE IN ELDERLY PATIENTS WITH CHRONIC HEART FAILURE IN LONG TERM THERAPY WITH CARVEDILOL AND BISOPROLOL Abstract  similar documents
M. A. Statsenko, I. A. Sporova, S. V. Belenkova, N. N. Shilina
"... , морфофункциональные параметры сердца, вариабельность ритма сердца (ВРС) и качество жизни при длительной терапии ..."
 
Vol 2, No 2 (2006) CLINICAL EFFICACY AND PECULIARITY OF COMPLIANCE WITH 48-WEEK LONG THERAPY WITH EGILOK RETARD IN PATIENTS WITH MILD TO MODERATE HYPERTENSION Abstract  similar documents
V. E. Oleynikov, V. A. Budanova, A. V. Kulucin
"... качество жизни больных. Результаты.  Через 48 недель лечение продолжало 22 больных (73,3%). 5 больных ..."
 
Vol 14, No 3 (2018) TREATMENT ADHERENCE AND QUALITY OF LIFE OF PATIENTS WITH STABLE ISCHEMIC HEART DISEASE IN TREATMENT WITH NICORANDIL: INTERRELATION AND INTERACTION (ACCORDING TO THE RESULTS OF THE OBSERVATIONAL STUDY NIKEA) Abstract  similar documents
S. Yu. Martsevich, Yu. V. Lukina, N. P. Kutishenko, V. P. Voronina, O. V. Lerman, O. V. Gaisenok, T. A. Gomova, A. V. Ezhov, A. D. Kuimov, R. A. Libis, G. V. Matyushin, T. N. Mitroshina, G. I. Nechaeva, I. I. Reznik, V. V. Skibitsky, L. A. Sokolova, A. I. Chesnikova, N. V. Dobrynina, S. S. Yakushin
"... Цель. Оценить показатели качества жизни (КЖ) и их динамику у пациентов со стабильной ИБС в ..."
 
Vol 8, No 5 (2012) POSSIBLE PREDICTORS OF ATRIAL FIBRILLATION RECURRENCE IN LONG-TERM PROPHYLACTIC PROPAFENONE THERAPY Abstract  similar documents
R. D. Kurbanov, N. U. Zakirov, Sh. K. Azizov, Kh. M. Raubzhanov
"... перегородки (тМЖП) были значимо больше во 2 группе. Масса миокарда левого желудочка (ММЛЖ) через 6 мес была ..."
 
Vol 6, No 3 (2010) ASSOCIATION OF CLINICAL AND GENETIC FACTORS WITH LEFT VENTRICLE HYPERTROPHY IN ARTERIAL HYPERTENSION Abstract  PDF (Eng)  similar documents
T. Yu. Kuznetsova, D. V. Gavrilov, L. M. Samohodskaya, D. V. Rebrikov, S. A. Morozova, P. I. Makarevich, A. V. Kolotvin, A. B. Balatsky, A. Yu. Postnov, S. A. Boitsov
"... исследования, уве- личение массы миокарда левого желудочка (ММЛЖ) на 50 г/м2 сопровождается возрастанием ..."
 
Vol 2, No 2 (2006) THE WAYS OF SYMPATHETIC SYSTEM OVERACTIVITY BLOCKING: RILMENIDINE VERSUS ATENOLOL Abstract  similar documents
Y. R. Kasherininov, E. K. Shavarova, A. A. Shavarov, N. V. Vachrameeva, A. N. Krutikov, E. V. Smirnova, A. O. Коnrady, E. V. Shlyakhto
"... ). Определялся липидный спектр, выполнялась эхокардиография с расчетом массы миокарда левого желудочка (ММЛЖ) и ..."
 
Vol 14, No 3 (2018) ECONOMIC BURDEN OF HYPERCHOLESTEROLEMIA IN THE RUSSIAN FEDERATION Abstract  similar documents
A. V. Kontsevaya, Yu. A. Balanova, A. E. Imaeva, M. B. Khudyakov, O. I. Karpov, O. M. Drapkina
"... includes not only cost of its correction, but also the cost of treatment of diseases and complications ..."
 
Vol 14, No 2 (2018) RATIONAL PHARMACOTHERAPY IN CARDIOLOGY: FROM MINIMIZATION OF EXPENSES TO EFFECTIVE MANAGEMENT Abstract  similar documents
N. A. Nikolayev, Yu. P. Skirdenko, S. S. Bunova, A. V. Ershov
"... than the class or cost of medicines, the original or generic nature of the drugs, or their dosage ..."
 
Vol 7, No 5 (2011) COMPARATIVE EFFICACY AND SAFETY OF HYPOLIPIDEMIC THERAPY WITH GENERIC AND ORIGINAL MEDICINAL PRODUCTS OF SIMVASTATIN Abstract  similar documents
E. I. Tarlovskaya, Yu. A. Balandina, I. E. Sapozhnikova, N. S. Maksimchuk
"... , creatine phosphokinase were evaluated every 4 weeks. Cost-effectiveness ratio was calculated. Results. 11 ..."
 
Vol 6, No 4 (2010) PHARMACOECONOMIC ANALYSIS OF CARVEDILOL THERAPY IN PATIENTS WITH ARTERIAL HYPERTENSION AND METABOLIC RISK FACTORS (ACCORDING TO THE CAMELLIA STUDY) Abstract  similar documents
S. Y. Martsevich, N. P. Kutishenko, A. D. Deev, S. A. Shalnova, R. G. Oganov
"... Aim. To perform cost-effectiveness analysis of 24 weeks antihypertensive therapy based ..."
 
Vol 10, No 2 (2014) IMPACT OF ATRIAL FIBRILLATION ON THE NEAR AND LONG-TERM PROGNOSIS OF LIFE AFTER ACUTE MYOCARDIAL INFARCTION. THE DATA OF THE LIS-1 STUDY (LYUBERTSY MORTALITY STUDY OF PATIENTS WITH ACUTE MYOCARDIAL INFARCTION) Abstract  similar documents
S. Yu. Martsevich, N. P. Kutishenko, M. L. Gynzburg, L. Yu. Drozdova, A. D. Deev, V. P. Smirnov
"... НА БЛИЖАЙШИЙ И ОТДАЛЕННЫЙ ПРОГНОЗ ЖИЗНИ ПРИ ОСТРОМ ИНФАРКТЕ МИОКАРДА. ДАННЫЕ ИССЛЕДОВАНИЯ ЛИС-1 ..."
 
Vol 1, No 2 (2005) ASSESSMENT OF INFLUENCE OF BETAGISTIN IN COMBINATION WITH ANTIHYPERTENSIVE DRUGS ON QUALITY OF LIFE AND NEUROLOGICAL STATUS OF PATIENTS WITH STABLE ARTERIAL HYPERTENSION AND DIZZINESS Abstract  similar documents
G. V. Andreeva, S. Y. Martsevich, V. M. Gorbunov, O. A. Melnikov, V. P. Voronina, I. P. Zhigareva
"... влиянием на качество жизни (КЖ). Целью нашего исследования было оценить воздействие на КЖ и ..."
 
Vol 10, No 4 (2014) PHARMACOECONOMIC ANALYSIS OF ANTIHYPERTENSIVE DRUG COMBINATIONS USE Abstract  similar documents
E. I. Tarlovskaya, Y. A. Balandina, N. S. Maximchuk-Kolobova
"... without ischemic heart disease (n=56) were included into the study. Blood pressure (BP) dynamics and cost ..."
 
Vol 8, No 2 (2012) THE "NEW" DRUG CLASSES IN THE TREATMENT OF CHRONIC HEART FAILURE AND THEIR EVIDENCE BASE Abstract  similar documents
S. N. Tereshchenko, I. V. Zhirov, A. G. Kochetov, O. V. Uspenskaya
"... to treatment, induces additional costs or may be a reason of new side effects. Additional (to standard therapy ..."
 
Vol 11, No 5 (2015) Three-year dynamics and unsolved problems of lipid-lowering therapy Abstract  similar documents
V. A. Sergeeva
"... taken to correct and control lipid metabolism disorders were insignificant within 3 years. High costs ..."
 
Vol 10, No 2 (2014) EVALUATION OF ATRIAL CONTRACTILE FUNCTION DISORDERS AND FIBROSIS AS PREDICTORS OF CHRONIC HEART FAILURE Abstract  similar documents
O. M. Drapkina, E. V. Cherkunova
"... Chronic heart failure (CHF) is a major health problem in many countries now, and the cost ..."
 
Vol 6, No 6 (2010) EFFICACY AND SAFETY OF SINUS RHYTHM RESTORATION WITH AMIODARONE AND PROPAFENONE IN OUTPATIENTS, ECONOMIC ASPECTS (BASED ON DATA OF N.A. SEMASHKO NORTHERN MEDICAL CLINICAL CENTER) Abstract  similar documents
T. A. Istomina, E. V. Serdechnaya, L. A. Kulminskaya, B. A. Tatarskiy, E. V. Kazakevich, V. L. Lipskiy, S. I. Martyushov
"... ), and amiodarone 600-800 mg daily. The cost/effectiveness ratio (CER) was estimated. This ratio shows the cost ..."
 
Vol 11, No 6 (2015) Clinical and economic analysis of the use of apixaban for the treatment of venous thromboembolic events Abstract  similar documents
O. V. Shatalova
"... of the health care system. The cost analysis, "cost-effectiveness" analysis, "impact on the budget” analysis ..."
 
Vol 3, No 4 (2007) THE ALGORITHMIC MODEL OF LABORATORY DIAGNOSTICS OPTIMIZATION Abstract  similar documents
G. I. Nazarenko, O. V. Andropova
"... of algorithmic approach is able to optimize diagnostics and its costs. Various algorithmic models, their features ..."
 
Vol 8, No 2 (2012) COMPARISON OF PHARMACOKINETICS AND PHARMACODYNAMICS OF THE ORIGINAL AND GENERIC ENALAPRIL IN THE ELDERLY PATIENTS WITH ARTERIAL HYPERTENSION Abstract  similar documents
O. P. Bobrova, M. M. Petrova
"... of cost minimization analysis. Results. Original enalapril dose necessary to achieve the target blood ..."
 
Vol 12, No 1 (2016) Pharmacoeconomic analysis of heart rate slowing drugs in patients with ischemic heart disease Abstract  similar documents
E. I. Tarlovskaya, T. I. Chudinovskikh
"... Aim. To compare the efficacy and cost/effectiveness ratio of the original and generic bisoprolol ..."
 
Vol 12, No 5 (2016) Modulation of Cardiac Contractility – a New Method in the Treatment of Heart Failure Abstract  similar documents
A. A. Petrukhina, S. N. Tereshchenko, I. V. Zhirov
"... ), предшественника мозгового натрийуретического пептида (NT-proBNP). Проводилась оценка качества жизни по результатам ..."
 
Vol 6, No 2 (2010) EVALUATION BY PRACTICING DOCTORS OF THE MODERN PHARMACOTHERAPY POSSIBILITIES IN PATIENTS WITH ISCHEMIC HEART DISEASE. RESULTS OF DOCTOR INTERVIEW IN MOSCOW AND VORONEZH Abstract  similar documents
S. Yu. Martsevich, L. Yu. Drozdova, Yu. V. Lukina, N. V. Sinyagina, T. G. Kheliya
"... , respectively, considered high cost of statins as the main limit for its implementation. Conclusion. On one ..."
 
Vol 5, No 6 (2009) ORGANOPROTECTIVE EFFECTS OF THE FIXED COMBINATION OF ANGIOTENSIN-CONVERTING ENZYME INHIBITOR LISINOPRIL AND DIURETIC HYDROCHLOROTHIAZIDE Abstract  similar documents
E. A. Ryabikhin, M. E. Mozheiko
"... левого желудочка, эластические свойства магистральных артерий и качество жизни у больных артериальной ..."
 
Vol 9, No 3 (2013) NICOTINE REPLACEMENT THERAPY OF THE TOBACCO ADDICTION IN PREVENTION OF CARDIORESPIRATORY DISEASES Abstract  similar documents
M. G. Gambaryan
"... of cardiorespiratory diseases. Smoking cessation is the most cost-effective measure for prevention of cardiovascular ..."
 
Vol 7, No 6 (2011) DABIGATRAN ETEXILATE FOR PREVENTION OF CARDIOEMBOLIC COMPLICATIONS IN NONVALVULAR ATRIAL FIBRILLATION: HOW TO DO THE INTERVENTION MORE EFFECTIVE AND SAFER Abstract  similar documents
I. S. Yavelov
"... кровотечений, включая угро- жающие жизни и внутричерепные). При использова- Рациональная Фармакотерапия в ..."
 
Vol 7, No 1 (2011) THE CHOICE OF THE DRUG AMLODIPINE FOR THE HYPERTENSION TREATMENT FROM THE STANDPOINT OF ECONOMIC FEASIBILITY Abstract  similar documents
S. Yu. Martsevich, N. A. Dmitrieva, A. D. Deev, Yu. V. Lukina, L. A. Sokolova, V. V. Yakusevich
"... Aim. Тo compare the cost-effectiveness of antihypertensive therapy based on a generic and original ..."
 
Vol 13, No 1 (2017) IN MEMORY OF ALEXEY P. GOLIKOV Abstract  similar documents
статья Редкционная
"... После тяжелой продолжительной болезни 24 января 2017 г. ушел из жизни выдающийся ученый-клиницист ..."
 
Vol 15, No 1 (2019) Mikhail Ya. Ruda (13.02.1940 – 10.02.2019) Abstract  similar documents
article Editorial
"... Ушел из жизни выдающийся советский и российский кардиолог, клиницист, ученый с мировым именем ..."
 
Vol 11, No 6 (2015) The influence of concomitant diseases on a long-term prognosis in patients with chronic ischemic heart disease according to the PROGNOZ IBS register Abstract  similar documents
S. N. Tolpygina, S. Yu. Martsevich, A. D. Deev
"... заболеваний у больных ИБС составило 1,83. Наличие сопутствующих заболеваний ухудшало прогноз жизни ..."
 
Vol 9, No 5 (2013) ASSESSING FACTORS THAT FORM PATIENT’S ATTITUDE TO TREATMENT PRECEDING HOSPITALIZATION FOR ACUTE CORONARY SYNDROM (DATA OF QUESTIONNAIRE WITHIN THE LIS REGISTER) Abstract  PDF (Eng)  similar documents
Yu. V. Lukina, M. L. Gynzburg, V. P. Smirnov, S. Yu. Martsevich, N. P. Kutishenko, A. V. Fokina, E. V. Daniels
"... the importance of lowering drug costs. 11 patients of 272 respondents demanded more care from their doctor; 4 ..."
 
Vol 11, No 3 (2015) ANALYSIS OF THE INFLUENCE OF THROMBOEMBOLIC COMPLICATIONS PREVENTION WITH ORAL ANTICOAGULANTS ON BUDGET IN PATIENTS WITH NON-VALVULAR ATRIAL FIBRILLATION Abstract  similar documents
A. V. Rudakova
"... of them the cost of anticoagulation therapy was determined on the basis of the average weighted prices ..."
 
Vol 11, No 2 (2015) IN MEMORY OF ANDREY A. ALEXANDROV Abstract  similar documents
"...  жизни скоропостижно скончался Александров Андрей Алексеевич, доктор медицинских наук, профессор ..."
 
Vol 6, No 5 (2010) THE USE OF ANGIOTENSIN CONVERTING ENZYME INHIBITORS AFTER MYOCARDIAL INFARCTION. WHAT DO EVIDENCE-BASED MEDICINE DATA SPEAK FOR? Abstract  similar documents
S. Yu. Martsevich
"... фермента (АПФ) на прогноз жизни больных после инфаркта миокарда (ИМ). Представлены разные тактики ..."
 
Vol 7, No 4 (2011) THE STICH TRIAL — THE IMPORTANCE OF DRUGS IN PATIENTS WITH CORONARY ARTERY DISEASE WAS HIGHER THAN EXPECTED Abstract  similar documents
S. Yu. Martsevich, N. P. Kutishenko
"... жизни больных ишемической болезнью сердца, осложнившейся выраженной сердечной недостаточностью. ..."
 
Vol 14, No 5 (2018) In Memory of Prof. Pavel Ya. Dovgalevsky Abstract  similar documents
article Editorial
"... 25 августа 2018 г. на 71-м году жизни скончался известный ученый, талантливый педагог, директор ..."
 
Vol 6, No 6 (2010) COMBINATION THERAPY OF HYPERTENSION — A RELIABLE WAY TO TARGET ACHIEVE Abstract  similar documents
Yu. V. Lukina, S. Yu. Martsevich
"... ), предупреждение поражения органов-мишеней, улучшение качества жизни пациентов, страдающих АГ. Рассмотрены ..."
 
Vol 14, No 2 (2018) NEW DIRECT ORAL ANTICOAGULANTS FOR TREATMENT OF PATIENTS WITH ATRIAL FIBRILLATION IN REAL-WORLD SETTING Abstract  similar documents
Zh. D. Kobalava, S. V. Villevalde, A. A. Shavarov
"... is easy to follow and well accepted by patients despite of twice-daily dosing regimen. Healthcare cost ..."
 
Vol 1, No 1 (2005) ASSESSMENT OF QUALITY OF GENERICS IN CARDIOLOGY: REALITY AND POSSIBILITIES Abstract  similar documents
V. V. Yakusevich
"... it possible to decrease the costs of treatment. From the other side with the advent of big number of copies ..."
 
Vol 4, No 1 (2008) EFFECT OF ANGIOTENSIN-II RECEPTOR ANTAGONIST LOSARTAN AND ITS COMBINATION WITH DIURETICS ON MYOCARDIAL MORPHO-FUNCTIONAL CONDITIONS IN HYPERTENSIVE PATIENTS WITH LEFT VENTRICULAR HYPERTROPHY Abstract  similar documents
S. N. Tolpygina, E. V. Oschepkova, L. M. Sergakova, A. N. Rogoza
"... ССЗ способно улучшить прогноз жизни и снизить риск развития ос- ложнений. Хотя первичной целью лечения ..."
 
Vol 3, No 5 (2007) CLINICAL AND PHARMACOKINETIC EQUIVALENCE OF ORIGINAL AND GENERIC AMLODIPINE IN PATIENTS WITH MILD-TO-MODERATE ARTERIAL HYPERTENSION Abstract  similar documents
N. A. Belolipetskiy, S. N. Tolpygina, J. B. Zverkov, V. V. Pisarev, I. E. Koltunov, V. G. Belolipetskaya, S. J. Martsevich
"... Amlorus and Norvasc, respectively. Cost of Amlorus therapy per patient was 221 rbl/month in comparison ..."
 
1 - 100 of 800 Items 1 2 3 4 5 6 7 8 > >> 

Search tips:

  • Search terms are case-insensitive
  • Common words are ignored
  • By default articles containing any term in the query are returned (i.e., OR is implied)
  • Make sure that a word exists in an article by prefixing it with +; e.g., +journal +access scholarly academic
  • Combine multiple words with AND to find articles containing all terms; e.g., education AND research
  • Exclude a word by prefixing it with - or NOT; e.g., online -politics or online NOT politics
  • Search for an exact phrase by putting it in quotes; e.g., "open access publishing". Hint: Quoting Chinese or Japanese words will help you to find exact word matches in mixed-language fields, e.g. "中国".
  • Use parentheses to create more complex queries; e.g., archive ((journal AND conference) NOT theses)